KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Equity Ratio (2016 - 2025)

Eli Lilly (LLY) has disclosed Equity Ratio for 17 consecutive years, with 0.24 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 30.12% year-over-year to 0.24, compared with a TTM value of 0.24 through Dec 2025, up 30.12%, and an annual FY2025 reading of 0.24, up 30.12% over the prior year.
  • Equity Ratio was 0.24 for Q4 2025 at Eli Lilly, up from 0.21 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.24 in Q4 2025 and bottomed at 0.13 in Q2 2021.
  • Average Equity Ratio over 5 years is 0.05, with a median of 0.01 recorded in 2023.
  • The sharpest move saw Equity Ratio tumbled 2360.21% in 2021, then soared 47964.61% in 2025.
  • Year by year, Equity Ratio stood at 0.09 in 2021, then skyrocketed by 102.07% to 0.0 in 2022, then soared by 404.71% to 0.01 in 2023, then skyrocketed by 1853.73% to 0.18 in 2024, then surged by 30.12% to 0.24 in 2025.
  • Business Quant data shows Equity Ratio for LLY at 0.24 in Q4 2025, 0.21 in Q3 2025, and 0.02 in Q2 2025.